共 50 条
- [31] Effectiveness and safety of vedolizumab for the induction of remission in inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2016, 10 : S416 - S417
- [34] Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases [J]. Digestive Diseases and Sciences, 2019, 64 : 1651 - 1659
- [35] Post induction infliximab trough levels predict long-term endoscopic remission in paediatric patients with inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S362 - S363
- [38] Infliximab trough levels for remission induction and long term therapy management of inflammatory bowel disease [J]. JOURNAL OF CROHNS & COLITIS, 2017, 11 : S386 - S386
- [39] Long-term impact of the decrease of infliximab trough levels on the disease course in Inflammatory Bowel Disease patients under maintenance treatment with infliximab [J]. JOURNAL OF CROHNS & COLITIS, 2020, 14 : S375 - S376